Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 2 |
| Takeda Pharmaceuticals International AG, Medical Devices Deals, 2010 to YTD 2016 | 10 | 1 |
| Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 11 | 3 |
| Takeda Pharmaceuticals International AG, Pharmaceuticals &Healthcare, Deal Details | 14 | 39 |
| Partnerships | 14 | 1 |
| Takeda Pharma International Terminates Co-Promotion Agreement With Merck For Daxas | 14 | 1 |
| Nycomed Enters Into Co-Marketing Agreement With Orion For Easyhaler | 15 | 2 |
| Nycomed Enters Into Co-Marketing Agreement With Almirall | 17 | 1 |
| Nycomed Enters Into Distribution Agreement With Almirall, Anika, Bionorica, CSL And Helsinn | 18 | 2 |
| Mitsubishi Tanabe Pharma Terminates Its Co-Development Agreement With Nycomed International | 20 | 1 |
| Essen BioScience Enters Into Collaboration Agreement With Nycomed | 21 | 1 |
| Nycomed International Management Enters Into Distribution Agreement With Vifor Pharma For Intravenous Iron Products | 22 | 1 |
| Nycomed Enters Into Co-Promotion Agreement With Merck | 23 | 2 |
| Nycomed Enters Into Co-Marketing Agreement With Merck | 25 | 2 |
| Ayanda Enters Into Distribution Agreement With Nycomed For CONCORDIX | 27 | 1 |
| Licensing Agreements | 28 | 1 |
| Valeant Canada Enters into Licensing Agreement with Takeda Pharma for Edarbi and Edarbyclor | 28 | 2 |
| Apricus Biosciences Enters Into Licensing Agreement With Takeda Pharma For Vitaros | 30 | 2 |
| Nycomed International Terminates Licensing Agreement With DURECT For POSIDUR | 32 | 2 |
| Nycomed Enters Into Licensing Agreement With Almirall For Ebastine | 34 | 1 |
| Nycomed Enters Into Licensing Agreement With Norgine For MOVIPREP | 35 | 2 |
| Nycomed Enters Into Licensing Agreement With Orion For Easyhaler | 37 | 2 |
| Nycomed Enters Into Licensing Agreement With F. Hoffmann-La Roche For Bonviva | 39 | 2 |
| DURECT Amends Licensing Agreement With Nycomed | 41 | 2 |
| Eurand Enters Into Licensing Agreement With Nycomed For ZENPEP | 43 | 2 |
| DURECT Amends Development And License Agreement With Nycomed | 45 | 1 |
| Acquisition | 46 | 1 |
| Takeda Pharma Completes Acquisition Of Nycomed International For US$13,681 Million | 46 | 4 |
| Nycomed Completes Acquisition Of Laboratorios Farmacol | 50 | 1 |
| Nycomed Acquires 51.34% Stake In Guangdong Techpool Bio-Pharma | 51 | 2 |
| Takeda Pharmaceuticals International AG - Key Competitors | 53 | 1 |
| Key Employees | 54 | 1 |
| Locations And Subsidiaries | 55 | 1 |
| Head Office | 55 | 1 |
| Appendix | 56 | 1 |
| Methodology | 56 | 1 |
| About GlobalData | 56 | 1 |
| Contact Us | 56 | 1 |
| Disclaimer | 56 | 1 |